Sponsored Webcast: Global Clinical Trial Disclosure: Are You Casting a Line or a Net?

Consider this: if a regulator questioned one of your trials tomorrow, could any single person in your organization account for every disclosure obligation it carries worldwide? As disclosure requirements continue to evolve, with authorities demanding greater transparency across diverse registries, timelines, and enforcement frameworks, this siloed model is no longer sustainable.

Clinical trial disclosure is typically managed at the jurisdiction level, with teams treating each country's registration and results-posting obligations as separate, isolated tasks. The "fishing line" approach, managing each requirement individually, may appear efficient on the surface, but can introduce significant risks, such as:

Duplicated effort, as teams repeat work that could satisfy multiple jurisdictions at once.
Inconsistent records across registries and public platforms.
Missed obligations, when no single team holds a comprehensive view of global requirements.

This webinar will make the case for a "fishing net" approach: a global, holistic framework that captures overlapping and interdependent obligations through a coordinated strategy. Rather than asking "What does Country X require?" in isolation, participants will learn to consider how a single disclosure activity can support obligations across multiple jurisdictions, where WHO primary registry status and ICMJE recognition deliver cross-border value, and where specific local requirements still demand targeted, non-substitutable action. Drawing on the latest disclosure developments and emerging trends, we will explore how an integrated strategy reduces duplication, strengthens compliance, and keeps trial information accurate and consistently available across global platforms. By shifting from a reactive, jurisdiction-by-jurisdiction model to a strategic global approach, sponsors can cast a single "catch all" net that captures the widest possible reach.

Learning Objectives

Upon completion of this webinar, participants will be able to:

Explain the limitations and hidden risks of a jurisdiction-by-jurisdiction ("fishing line") approach to clinical trial disclosure, including duplicated effort, inconsistent records, and missed obligations.
Identify where a single disclosure activity can satisfy obligations across multiple jurisdictions, and where WHO primary registry status and ICMJE recognition provide cross-border value.
Distinguish obligations that can be met through cross-recognition from local requirements that demand targeted, non-substitutable action.
Describe how an integrated, global disclosure strategy and systems reduce duplication, strengthen compliance, and keep trial information consistently available across regulatory and public platforms, using a structured operating model such as CLARITY and a staged implementation roadmap.

Who Should Attend?

This webinar is designed for clinical trial disclosure and transparency professionals, regulatory affairs and compliance teams, and clinical operations leaders responsible for registration and results-posting obligations. Additionally, it will be valuable to sponsors, CROs, and biopharma organizations seeking to coordinate disclosure across multiple markets, as well as professionals tasked with building or improving a global transparency strategy.

Audience Learning Level

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.